when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Marketed
naltrexone hydrochloride
Lodonal (naltrexone hydrochloride)
Autoimmune Hepatitis Biostax Corp
Phase 3
namodenoson
namodenoson
Hepatocellular Carcinoma$CANF Can-Fite BioPharma Ltd.
Preclinical
nanoencorafenib
Colorectal Cancer Nanoform Finland Plc
Phase 3

page 234 of 271

nanvuranlat [INN]

Metastatic Biliary Tract Cancer

J-Pharma Co Ltd

Phase 3

Mitochondrial Diseases Abliva AB

Preclinical

Sickle Cell Disease With Vaso-Occlusive Crisis Fera Pharmaceuticals LLC

Marketed

Ankylosing Spondylitis (Bekhterev's Disease) NuCare Pharmaceuticals Inc

Marketed

naproxen sodium ER

Naproxen Sodium Alvogen (naproxen sodium)

Primary Dysmenorrhea Alvogen Inc

Marketed

naratriptan hydrochloride

Naratriptan (naratriptan hydrochloride)

Migraine Orchid Pharma Inc

Phase 2

narmafotinib tartrate

narmafotinib tartrate

Metastatic Adenocarcinoma of The Pancreas Amplia Therapeutics Ltd

Phase 2

Diabetic Gastroparesis Renexxion LLC

Marketed

Tysabri (natalizumab)

Crohn's Disease (Regional Enteritis)$BIIB BIOGEN INC.

Marketed

Natacyn (natamycin)

Blepharitis$HROW HARROW, INC.

Marketed

Type 2 Diabetes Modavar Pharmaceuticals LLC

Phase 3

navacaprant hydrochloride

navacaprant hydrochloride

Major Depressive Disorder$NMRA Neumora Therapeutics, Inc.

Phase 3

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…$BCRX BIOCRYST PHARMACEUTICALS INC

Phase 2

Fallopian Tube Cancer Feng Biosciences Inc

Phase 3

navitoclax dihydrochloride

navitoclax dihydrochloride

Myelofibrosis$ABBV AbbVie Inc.

Phase 2

Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Kartos Therapeutics Inc

Phase 2

Danyelza (naxitamab-gqgk)

Neuroblastoma Y-mAbs Therapeutics Inc

Phase 3

Refractory Acute Myeloid Leukemia$MBRX Moleculin Biotech, Inc.

Marketed

nebivolol hydrochloride

Nebivolol Hydrochloride

Hypertension Beximco Pharmaceuticals USA Inc

Phase 2

Primary Sclerosing Cholangitis$CMMB Chemomab Therapeutics Ltd.

Marketed

Portrazza (necitumumab)

Squamous Non-Small Cell Lung Cancer Eli Lilly and Co

Preclinical

nedaplatin [INN]

Esophageal Cancer RNR BioMedical Inc

Phase 2

Neurofibromatoses Type I (Von Recklinghausen's Disease) NFlection Therapeutics Inc

Marketed

nedosiran sodium

Rivfloza (nedosiran sodium)

Primary Hyperoxaluria Type II Novo Nordisk AS

Marketed

nefazodone hydrochloride

Nefazodone Hydrochloride

Major Depressive Disorder Teva Pharmaceuticals USA Inc

Phase 2

Frontotemporal Dementia (Pick Disease)$CRVO CervoMed Inc.

pre_registration

Non-Small Cell Lung Cancer$NUVL Nuvalent, Inc.